Gladstone NOW: The Campaign Join Us on the Journey ✕
31 - 43 of 43 Results Clear All
New insights into how a gene causes damage could impact future drug development
News Release Research (Publication) Alzheimer’s Disease Neurological Disease Huang Lab
A new center at Gladstone aims to find unforeseen uses for existing drugs
Huang Lab Stem Cells/iPSCs Alzheimer’s Disease
E-Scape Bio, a Gladstone spin-off company, extends its Series A financing to generate novel therapies to treat neurodegenerative disorders
Huang Lab Mahley Lab Alzheimer’s Disease
Gladstone scientists combine expertise in Alzheimer’s research with legacy as leaders in stem cell technology
Alzheimer’s Disease Gan Lab Huang Lab CRISPR/Gene Editing Stem Cells/iPSCs
Scientists at the Gladstone Institutes take a comprehensive approach to dementia research, pursuing several potential causal factors of the disease in the hopes of discovering breakthrough treatments.
Alzheimer’s Disease Gan Lab Huang Lab Mucke Lab
Scientists at the Gladstone Institutes have discovered how the major genetic risk factor for Alzheimer’s disease causes memory impairment.
Alzheimer’s Disease Huang Lab
Gladstone scientists collaborate with teachers to facilitate career discussions and lab lessons for students in public high schools in San Francisco.
Finkbeiner Lab Huang Lab McDevitt Lab Yamanaka Lab
SAN FRANCISCO, CA—A new study from the Gladstone Institutes has revealed a way to alleviate the learning and memory deficits caused by apoE4, the most important genetic risk factor for Alzheimer’s disease, improving cognition to normal levels in aged mice.
Huang Lab Alzheimer’s Disease
SAN FRANCISCO, CA—Alzheimer’s disease is one of the greatest challenges facing modern medicine, but there is new hope in the fight against this deadly disease.
Huang Lab Mahley Lab Neurological Disease Alzheimer’s Disease
SAN FRANCISCO, CA—There is no easy way to study diseases of the brain. Extracting brain cells, or neurons, from a living patient is difficult and risky, while examining a patient’s brain post-mortem usually only reveals the disease’s final stages.
Huang Lab Alzheimer’s Disease Stem Cells/iPSCs
SAN FRANCISCO, CA—Scientists at the Gladstone Institutes are recommending a shift in efforts to treat Alzheimer’s disease by developing drugs that target the apoE4 protein, which has long been associated with an increased risk for the disease.
Alzheimer’s Disease Huang Lab Mahley Lab
SAN FRANCISCO, CA—Alzheimer's disease is an extremely complicated disease. Several proteins seem to be involved in its cause and progression.
Alzheimer’s Disease Huang Lab
SAN FRANCISCO, CA—Stimulating the growth of new neurons to replace those lost in Alzheimer's disease (AD) is an intriguing therapeutic possibility. But will the factors that cause AD allow the new neurons to thrive and function normally?
Alzheimer’s Disease Gan Lab Huang Lab
